SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes-Reference-Cited by-同舟云学术

SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes

Published:2023-11-14 Issue:1 Volume:47 Page:e4-e5
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Hayes Annabelle G.¹^ORCID,Raven Lisa M.¹²³^ORCID,Viardot Alexander¹²³,Kotlyar Eugene³⁴⁵,Greenfield Jerry R.¹²³

Affiliation:

1. 1Department of Diabetes and Endocrinology, St Vincent’s Hospital, Sydney, Australia

2. 2Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia

3. 3School of Clinical Medicine, St Vincent’s Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia

4. 4Department of Heart and Lung Transplantation, St Vincent’s Hospital, Sydney, Australia

5. 5Victor Chang Cardiac Research Institute, Sydney, Australia

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/47/1/e4/741631/dc231903.pdf

Reference5 articles.

1. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;Circulation,2022

2. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

3. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the Association of SGLT-2 inhibitors and diabetic ketoacidosis;Handelsman;Endocr Pract,2016

4. Sodium glucose cotransporter 2 inhibitor-induced ketoacidosis is unlikely in patients without diabetes;Raven;Med J Aust,2023

5. Peri-procedural ketoacidosis risk with sodium-glucose cotransporter 2 inhibitor use in people without diabetes;Milder;Anaesthesia,2023

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Treatment with SGLT-2 Inhibitors is Associated with ICU Admission and Disease Severity in Patients with Diabetic Ketoacidosis: A Propensity Score–Matched Cohort Study;2024-09-09

2. Euglycemic Ketoacidosis in a Patient without Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure;American Journal of Case Reports;2024-06-03

3. Increasing patient awareness of ketoacidosis with gliflozins;Prescriber;2024-05

4. Applications of SGLT2 inhibitors beyond glycaemic control;Nature Reviews Nephrology;2024-04-26